VSTM
Price
$7.87
Change
-$0.06 (-0.76%)
Updated
Dec 24 closing price
Capitalization
592.77M
Intraday BUY SELL Signals
VTGN
Price
$0.73
Change
+$0.02 (+2.82%)
Updated
Dec 24 closing price
Capitalization
28.75M
Intraday BUY SELL Signals
Interact to see
Advertisement

VSTM vs VTGN

Header iconVSTM vs VTGN Comparison
Open Charts VSTM vs VTGNBanner chart's image
Verastem
Price$7.87
Change-$0.06 (-0.76%)
Volume$734.78K
Capitalization592.77M
VistaGen Therapeutics
Price$0.73
Change+$0.02 (+2.82%)
Volume$1.77M
Capitalization28.75M
VSTM vs VTGN Comparison Chart in %
VSTM
Daily Signal:
Gain/Loss:
VTGN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
VSTM vs. VTGN commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VSTM is a Buy and VTGN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (VSTM: $7.87 vs. VTGN: $0.73)
Brand notoriety: VSTM and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: VSTM: 30% vs. VTGN: 62%
Market capitalization -- VSTM: $592.77M vs. VTGN: $28.75M
VSTM [@Biotechnology] is valued at $592.77M. VTGN’s [@Biotechnology] market capitalization is $28.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VSTM’s FA Score shows that 0 FA rating(s) are green whileVTGN’s FA Score has 1 green FA rating(s).

  • VSTM’s FA Score: 0 green, 5 red.
  • VTGN’s FA Score: 1 green, 4 red.
According to our system of comparison, VSTM is a better buy in the long-term than VTGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VSTM’s TA Score shows that 4 TA indicator(s) are bullish while VTGN’s TA Score has 4 bullish TA indicator(s).

  • VSTM’s TA Score: 4 bullish, 5 bearish.
  • VTGN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, VSTM is a better buy in the short-term than VTGN.

Price Growth

VSTM (@Biotechnology) experienced а -1.13% price change this week, while VTGN (@Biotechnology) price change was -15.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VSTM($593M) has a higher market cap than VTGN($28.7M). VSTM YTD gains are higher at: 52.224 vs. VTGN (-75.325). VTGN has higher annual earnings (EBITDA): -64.79M vs. VSTM (-238.62M). VSTM has more cash in the bank: 138M vs. VTGN (77.2M). VTGN has less debt than VSTM: VTGN (1.87M) vs VSTM (89.5M). VSTM has higher revenues than VTGN: VSTM (13.4M) vs VTGN (721K).
VSTMVTGNVSTM / VTGN
Capitalization593M28.7M2,066%
EBITDA-238.62M-64.79M368%
Gain YTD52.224-75.325-69%
P/E RatioN/AN/A-
Revenue13.4M721K1,859%
Total Cash138M77.2M179%
Total Debt89.5M1.87M4,799%
FUNDAMENTALS RATINGS
VSTM vs VTGN: Fundamental Ratings
VSTM
VTGN
OUTLOOK RATING
1..100
6366
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
17
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
4298
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTGN's Valuation (17) in the Biotechnology industry is somewhat better than the same rating for VSTM (61). This means that VTGN’s stock grew somewhat faster than VSTM’s over the last 12 months.

VTGN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as VSTM (100). This means that VTGN’s stock grew similarly to VSTM’s over the last 12 months.

VTGN's SMR Rating (98) in the Biotechnology industry is in the same range as VSTM (100). This means that VTGN’s stock grew similarly to VSTM’s over the last 12 months.

VSTM's Price Growth Rating (42) in the Biotechnology industry is somewhat better than the same rating for VTGN (98). This means that VSTM’s stock grew somewhat faster than VTGN’s over the last 12 months.

VSTM's P/E Growth Rating (100) in the Biotechnology industry is in the same range as VTGN (100). This means that VSTM’s stock grew similarly to VTGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
VSTMVTGN
RSI
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
86%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
80%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
VSTM
Daily Signal:
Gain/Loss:
VTGN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AFOCX24.040.11
+0.46%
Archer Focus
CMLIX49.810.14
+0.28%
Congress Large Cap Growth Institutional
RAGTX76.600.17
+0.22%
Virtus Zevenbergen Technology A
SVBAX29.530.06
+0.20%
JHancock Balanced A
ISCTX21.630.02
+0.09%
Voya SmallCap Opportunities Port S2

VSTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, VSTM has been loosely correlated with ZLDAF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if VSTM jumps, then ZLDAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VSTM
1D Price
Change %
VSTM100%
-0.76%
ZLDAF - VSTM
47%
Loosely correlated
N/A
MDGL - VSTM
37%
Loosely correlated
+0.10%
VTGN - VSTM
34%
Loosely correlated
+2.08%
DYN - VSTM
34%
Loosely correlated
-0.29%
SYRE - VSTM
33%
Poorly correlated
-0.54%
More

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with KYTX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
+2.08%
KYTX - VTGN
44%
Loosely correlated
+1.24%
IPSC - VTGN
39%
Loosely correlated
+6.19%
SYRE - VTGN
38%
Loosely correlated
-0.54%
REPL - VTGN
38%
Loosely correlated
+3.81%
IDYA - VTGN
38%
Loosely correlated
+0.76%
More